Literature DB >> 11117409

Formation of proliferative vitreoretinopathy in primary rhegmatogenous retinal detachment.

J M Hooymans1, V W De Lavalette, A G Oey.   

Abstract

Proliferative vitreoretinopathy (PVR) is the only cause of ultimate failure following retinal detachment surgery. This study aimed to review the rate of postoperative PVR in a series of 186 consecutive patients with primary rhegmatogenous retinal detachments. All 186 detachments were repaired with a scleral buckling procedure combined with cryotherapy. Drainage of subretinal fluid was done at the discretion of the surgeon. The mean follow-up was 12 months. In this series 152 (82%) of primary detachments were repaired succesfully with a single operation. Sixty-eight percent of patients regained 0.3 or better visual acuity, and 3% of patients were left with visual acuity of 1/60 or less. After two or more operations the retina was attached in 96% of the cases. In 12 (6%) eyes PVR was responsible for the initial surgical failure. In 4 cases PVR (grade B and limited C) was present prior to surgery. In 3 cases PVR developed within 2 days postoperatively, in 3 cases after 3-6 weeks and in another 2 cases after 8-10 months. Eight out of 12 (66%) PVR patients had undergone cataract surgery. One PVR case had preoperative intraocular inflammation. An association between the duration of retinal detachment, or drainage of subretinal fluid and the development of PVR could not be demonstrated. In conclusion, the rate of postoperative PVR in primary rhegmatogenous retinal detachments was low. PVR preoperatively present and pseudophakia may be risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 11117409     DOI: 10.1023/a:1002428928803

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  4 in total

1.  Scleral buckling for retinal detachment. Predictors for anatomic failure.

Authors:  T Sharma; J K Challa; K V Ravishankar; R Murugesan
Journal:  Retina       Date:  1994       Impact factor: 4.256

Review 2.  Management of anterior and posterior proliferative vitreoretinopathy. XLV. Edward Jackson memorial lecture.

Authors:  T M Aaberg
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

3.  A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling.

Authors:  W S Grizzard; G F Hilton; M E Hammer; D Taren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

4.  Retinal detachment in Olmsted County, Minnesota, 1976 through 1995.

Authors:  J A Rowe; J C Erie; K H Baratz; D O Hodge; D T Gray; L Butterfield; D M Robertson
Journal:  Ophthalmology       Date:  1999-01       Impact factor: 12.079

  4 in total
  5 in total

Review 1.  [Scleral buckling surgery and pneumatic retinopexy. Techniques, indications and results].

Authors:  H Hoerauf; H Heimann; L Hansen; H Laqua
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

Review 2.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2021-10-18       Impact factor: 1.779

3.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

4.  Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol.

Authors:  Rishika Chaudhary; Janine Dretzke; Robert Scott; Ann Logan; Richard Blanch
Journal:  Syst Rev       Date:  2016-07-08

5.  Reviving the lost art of scleral buckling surgery for rhegmatogenous retinal detachment: evaluation of risk factors of detachments, poor physiological outcomes, and perspective from a developing country.

Authors:  Sweta Singh; Anadi Khatri; Raghunandan Byanju; Muna Kharel; Kriti Joshi; Saru Khadka Thapa
Journal:  Ther Adv Ophthalmol       Date:  2019-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.